Work

Defining immunological biomarkers for head-and-neck-cancer: First Erlanger results of the prospective ImmunBioKHT trial

Year: 2024

Type: conference-paper

Abstract: Background: Immunological biomarkers are becoming increasingly important in the classification and treatment of head and neck cancer (HNSCC). These markers include the expression of immune checkpoint molecules, but also various immune cell (sub)types. However, HNSCC not only interact with the immune [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/24hnosw03

Authors: Donaubauer, Anna-Jasmina, Vogl, Christoph, Allner, Moritz, Balk, Matthias, Kahl, Klaus Henning, Gaipl, Udo S., Kesting, Marco, Müller, Sarina, Fietkau, Rainer, Weber, Manuel, Hecht, Markus, Gostian, Antoniu-Oreste, Frey, Benjamin

Institutions: Universitätsklinikum Erlangen, University Hospital Augsburg, Universitätsklinikum des Saarlandes, Saarland University, Barmherzige Brüder Klinikum St. Elisabeth in Straubing

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6927304958

FWCI:

Cites:

Cited by:

Related to: